1. Home
  2. AAPG vs PHI Comparison

AAPG vs PHI Comparison

Compare AAPG & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • PHI
  • Stock Information
  • Founded
  • AAPG 2009
  • PHI 1928
  • Country
  • AAPG China
  • PHI Philippines
  • Employees
  • AAPG N/A
  • PHI N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • PHI Telecommunications Equipment
  • Sector
  • AAPG Health Care
  • PHI Telecommunications
  • Exchange
  • AAPG Nasdaq
  • PHI Nasdaq
  • Market Cap
  • AAPG 3.6B
  • PHI 4.1B
  • IPO Year
  • AAPG 2025
  • PHI 1953
  • Fundamental
  • Price
  • AAPG $33.87
  • PHI $20.93
  • Analyst Decision
  • AAPG Strong Buy
  • PHI Hold
  • Analyst Count
  • AAPG 3
  • PHI 1
  • Target Price
  • AAPG $49.00
  • PHI N/A
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • PHI 124.2K
  • Earning Date
  • AAPG 11-19-2025
  • PHI 11-11-2025
  • Dividend Yield
  • AAPG N/A
  • PHI 5.79%
  • EPS Growth
  • AAPG N/A
  • PHI 9.36
  • EPS
  • AAPG N/A
  • PHI 2.32
  • Revenue
  • AAPG $54,524,554.00
  • PHI $3,761,997,877.00
  • Revenue This Year
  • AAPG N/A
  • PHI $3.27
  • Revenue Next Year
  • AAPG $368.64
  • PHI $3.07
  • P/E Ratio
  • AAPG N/A
  • PHI $9.21
  • Revenue Growth
  • AAPG N/A
  • PHI 1.69
  • 52 Week Low
  • AAPG $16.50
  • PHI $18.61
  • 52 Week High
  • AAPG $48.45
  • PHI $25.12
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • PHI 69.56
  • Support Level
  • AAPG $30.93
  • PHI $19.02
  • Resistance Level
  • AAPG $34.31
  • PHI $21.17
  • Average True Range (ATR)
  • AAPG 0.81
  • PHI 0.43
  • MACD
  • AAPG 0.26
  • PHI 0.24
  • Stochastic Oscillator
  • AAPG 85.99
  • PHI 91.40

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: